Forge offers comprehensive characterization of plasmid and AAV gene therapy products through a hybrid sequencing approach for clients.
Connect with our experts to learn more about how this in-house service is seamlessly integrated into our end-to-end plasmid and AAV manufacturing offerings.
New pathways are forged together
-1.png?width=787&height=525&name=MicrosoftTeams-image%20(166)-1.png)
We offer continuous AAV manufacturing and development services to accelerate gene therapy programs from research through clinical and on to commercial manufacturing

We provide Research-Grade, GMP-Pathway, and cGMP plasmid DNA manufacturing that incorporates seamlessly into our clients' AAV manufacturing

Forge’s proprietary HEK293 suspension Ignition Cells™ and pEMBR™ ad helper plasmid help gene therapy developers accelerate their programs safely, quickly, and at scale